Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Atellica CH High Sensitivity C-Reactive Protein (HsCRP) Calibrator - Product Usage: For in vitro diagnostic use in the calibration of ADVIA Chemistry systems for the CardioPhase hsCRP assay

FDA Recall Z-1261-2020 · Posted None

Recalling FirmSiemens Healthcare Diagnostics, Inc.
Recall StatusTerminated
Product CodeJIX
Date Initiated2019-11-19
Date Terminated2021-08-30
Product Quantity1306

Reason for Recall

Atellica CH: The Atellica CH High Sensitivity CReactive Protein Calibrator (hsCRP CAL) is for in vitro diagnostic use in calibrating the hsCRP assay using the Atellica CH Analyzer.

Firm Action

On November 19, 2019 the firm distributed Urgent Medical Device Recall Communication letters by mail stating: Urgent Medical Device Correction Our records indicate that your facility may have received the following product: Atellica CH 930 Analyzer Reassignment of the Atellica CH High Sensitivity C-Reactive Protein (hsCRP) Calibrator Lot 453716 (Ref/Siemens Material Number 11099412/11099412) ADVIA Chemistry Systems Reassignment of the ADVIA Chemistry CardioPhase High Sensitivity C-Reactive Protein (hsCRP) Calibrator Lot 453610 (Ref/Siemens Material Number -05006455/10335897) Reason for Correction The purpose of this communication is to inform you of an issue with the product indicated above and provide instructions on actions that your laboratory must take. Siemens has confirmed that the current assigned values for ADVIA Chemistry hsCRP Calibrator Lot 453610 demonstrate a positive bias of approximately 11% for hsCRP patient samples and Quality Control material when compared to the European Reference Material ERM DA474/IFCC for CRP measurement. Depending on the QC concentrations and ranges used by the laboratory, QC may not detect this issue. To correct for the positive bias, the values for ADVIA Chemistry hsCRP Calibrator Lot 453610 have been reassigned to align with reference material ERM DA474/IFCC. The information in Table 2 supersedes the information in the calibrator lot-specific value sheet for hsCRP Calibrator Lot 453610. Refer to Table 2 for the reassigned calibrator values. Patient and Quality Control results are expected to shift approximately -11% when using the reassigned calibrator values for Lot 453610. Based on the negative shift in recovery, it may be necessary to adjust your laboratorys quality control ranges. Refer to Table 3 for representative quality control recovery data. Future commercial calibrator lots will be traceable to this new reference material and will demonstrate comparable performance to the reassig

Root Cause

No Marketing Application

Distribution Pattern

Worldwide distribution US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, NC, NE, NH, NJ, NM, NV, NY, OH, OR, PA, SC, TN, TX, UT, WA, WY and countries of UK, CA, PH, MX, VN, TW, TH, IN, CO, AE, AR, AU, BD, BE, BG, BR, CL, CZ, DE, DK, EG, ES, FI, FR, GR, HU, IE, IT, KR, MY, NL, PL, PT, RO, RU, SE, SG.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

K081294ADVIA CHEMISTRY CARDIOPHASE HIGH SENSITIVITY C-REACTIVE PROTEIN (HSCRP), CALIBRATORSSiemens Healthcare Diagnostics, Inc. · 2008-07-29

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑